ABSTRACT Dietary fats affect health and disease. The assimilation of dietary fats into the body requires that they be digested by lipases. One lipase, pancreatic triglyceride lipase, is essential for the efficient digestion of dietary fats. Pancreatic triglyceride lipase is the archetype of the lipase gene family that includes two homologues of pancreatic triglyceride lipase, pancreatic lipase-related proteins 1 and 2. In recent years, important advances have been made in delineating the mechanisms of lipolysis. The cDNA sequences encoding pancreatic triglyceride lipase and the related proteins have been described. The tertiary structure of human pancreatic triglyceride lipase has been determined alone and in a complex with colipase, a pancreatic protein required for lipase activity in the duodenum. This structural information has allowed the rational design of site-specific mutants of pancreatic triglyceride lipase. Together with the structural information, these mutants have greatly advanced our understanding of the molecular details governing lipolysis. This review describes these studies, which will eventually provide the background for the rational design of nutrition therapy in patients with pancreatic insufficiency and fat malabsorption.
According to the two-phase model of dietary fat digestion, of their resemblance to pancreatic triglyceride lipase (Giller the concerted action of preduodenal and duodenal lipases diet al. 1992 , Grusby et al. 1990 , Payne et al. 1994 , Wishart et gests dietary fats into sn-2 monoacylglycerols and free fatty al. 1993). The roles of pancreatic triglyceride lipase-related acids (Hofmann and Borgstrom 1962 and 1964) . These prodprotein 1 and pancreatic triglyceride lipase-related protein ucts are solubilized with bile salts to form mixed micelles that 2 in fat digestion are not known, but their description and facilitate the absorption of the fatty acids across the enterocyte characterization along with the determination of the tertiary membrane. In humans, digestion begins in the stomach where structure of pancreatic triglyceride lipase and the characterizagastric lipase, an acid lipase synthesized by gastric chief cells, tion of recombinant pancreatic triglyceride lipase mutants releases about 15% of the fatty acids (Carrière et al. 1993) .
have provided insights into the biochemical mechanism of Lipases, secreted by pancreatic acinar cells, complete fat digeslipolysis and the physiology of dietary fat digestion. tion in the proximal small intestine.
Three of the lipases expressed by the pancreas have highly LIPASE GENE FAMILY homologous structures. One of these, colipase-dependent triLipases are ubiquitous hydrolases required for all aspects of glyceride lipase is clearly essential for efficient dietary fat digesfat metabolism (Carey and Hernell 1992) . Triglyceride lipases tion as evidenced by the steatorrhea present in patients with that hydrolyze the ester bonds in triacylglycerols are found in congenital pancreatic triglyceride lipase deficiency (Figarella the gastrointestinal tract, bound to epithelial surfaces and in et al. 1980 et al. , Ghishan et al. 1984 . The exact proportion of acyl side adipocytes. Many lipases have many common functional chains released by pancreatic triglyceride lipase is not clearly and enzymatic properties and some have strong homology of defined, but data in patients with congenital pancreatic triglyctheir primary amino acid sequences. For instance, three triglyceride lipase deficiency suggest that pancreatic triglyceride lieride lipases, pancreatic triglyceride lipase, hepatic lipase and pase digests at least 50% of dietary triglycerides. The other lipoprotein lipase are similar in size, and alignment of their two homologous proteins were recently described and have amino acid sequences revealed 33 and 30% identity of pancrebeen called pancreatic lipase-related proteins 1 and 2 because atic triglyceride lipase with lipoprotein and hepatic lipases, respectively. Based on this homology, Kirchgessner et al. (1987) proposed that a lipase gene family arose from a common ture for the human genes encoding pancreatic triglyceride lipase, hepatic lipase and lipoprotein lipase showed conservation of the exon-intron divisions, which indicated that the genes are related (Kirchgessner et al. 1989 , Sims et al. 1993 ). Furthermore, an Alu element, a repetitive DNA sequence, was present in the corresponding introns of pancreatic triglyceride lipase and lipoprotein lipase. Classification of the Alu sequences suggested that the genes diverged within the last 40-50 million years (Chuat et al. 1992 , Sims et al. 1993 . The description of the human pancreatic triglyceride lipase-related proteins added two new members to the lipase gene family (Giller et al. 1992) . Pancreatic triglyceride lipaserelated protein 1 was 68% identical to pancreatic triglyceride lipase and the related protein 2 was 65% identical to pancreatic triglyceride lipase (see below). Additionally, the gene encoding dog pancreatic triglyceride lipase-related protein 1 has FIGURE 1 Secretion of pancreatic triglyceride lipase (PL), pancrean exon-intron organization identical to that of pancreatic atic triglyceride lipase-related protein 1 (PLRP1), and pancreatic tritriglyceride lipase (Mickel et al. 1989 nal lumen to finish fat digestion. Less is known about the pancreatic triglyceride lipase-related proteins. mRNA encoding pancreatic triglyceride lipase-related protein 1 is expressed related proteins was suggested by examining the temporal pattern of expression for all three genes during development in in the pancreas, but nothing is known about the expression of pancreatic triglyceride lipase-related protein 1 in other the rat (Payne et al. 1994 ). In the adult human pancreas, the mRNA encoding pancreatic triglyceride lipase-related protissues (Giller et al. 1992 , Payne et al. 1994 . mRNA encoding rat pancreatic triglyceride lipase-related protein 2 was reteins 1 and 2 were 4-and 24-fold lower, respectively, than the mRNA for pancreatic triglyceride lipase (Giller et al. 1992 ). ported in the pancreas, but was not detected in other tissues by RNA blot (Wishart et al. 1993) . Pancreatic triglyceride Similar distributions were observed in the adult rat pancreas, but the pattern was quite different in the newborn rat (Payne lipase-related protein 2 mRNA and protein was found in cytotoxic T-cells after subculture in medium containing inet al. 1994) . In newborns, mRNA encoding pancreatic lipaserelated protein 1 predominated. mRNA encoding pancreatic terleukin 4, but its presence in circulating lymphocytes has not been established (Grusby et al. 1990 ). These authors spectriglyceride lipase-related protein 2 was present at lower levels, and mRNA encoding pancreatic triglyceride lipase was ulated that pancreatic triglyceride lipase-related protein 2 might play a role in cytotoxicity by acting upon lipids in not detected. This initial observation suggested that the three mRNA species were discordantly regulated during developcellular membranes.
The presence of mRNA does not ensure that the mRNA ment.
To expand this observation, the presence of mRNA encodis translated and the protein is expressed. The protein must be detected by other means. Both pancreatic triglyceride lipaseing each species was determined by dot-blot analysis of pancreas RNA harvested at various postnatal and prenatal ages. related protein 1 and pancreatic triglyceride lipase-related protein 2 were detected in the medium of AR42J cells, a cell
The mRNA encoding pancreatic triglyceride lipase, pancreatic triglyceride lipase-related protein 1 and pancreatic triglycerline with acinar cell properties, suggesting that these homologues may also be present in pancreatic secretions (Fig. 1) ide lipase-related protein 2 were low prior to birth (Fig. 2) . Within hours after birth, the mRNA encoding pancreatic tri- (Kuhlman et al. 1996) . Pancreatic secretions have not been examined for the presence of pancreatic triglyceride lipaseglyceride lipase-related protein 1 and pancreatic triglyceride lipase-related protein 2 rose to their maximum levels, whereas related protein 1 protein by any methods; thus, it is not known if pancreatic triglyceride lipase-related protein 1 is secreted the mRNA for pancreatic triglyceride lipase remained low. During the suckling period, the relative levels of mRNA enby the pancreas. Pancreatic triglyceride lipase-related protein 2 protein was detected by immunoblot in secretions obtained coding pancreatic triglyceride lipase-related protein 1 and pancreatic triglyceride lipase-related protein 2 fell to the from a cannulated rat pancreatic duct (Wagner et al. 1994) . Even though the presence of pancreatic triglyceride lipaselower levels found in the adult pancreas. In contrast, mRNA encoding pancreatic triglyceride lipase remained low until the related protein 2 in pancreatic secretions suggests that it may participate in fat digestion, the physiological function is not suckling-weanling transition when the levels reached adult values. Similar temporal regulation of the mRNA encoding known for either pancreatic triglyceride lipase-related protein 1 or pancreatic triglyceride lipase-related protein 2.
pancreatic triglyceride lipase may also occur in human infants because they have a relative deficiency of pancreatic triglycer-A clue to the function of the pancreatic triglyceride lipase- Payne et al. 1994 , Thirstrup et al. 1994 , Wicker-Planquart and Puigserver 1992 , Winkler et al. 1990 , Wishart et al. 1993 .
The primary sequences of pancreatic triglyceride lipase and the pancreatic triglyceride lipase-related proteins are remarkably conserved. Human and rat pancreatic triglyceride lipase are synthesized as 465 amino acid proteins with a short, 16 amino acid signal peptide. The mature protein is 449 amino acids (Lowe et al. 1989 , Payne et al. 1994 . Similarly, pancreatic triglyceride lipase-related protein 1 from both species has a short signal peptide of 17 amino acids, but the predicted sequence for the mature rat pancreatic triglyceride lipaserelated protein 1, originally reported as pancreatic triglyceride lipase but later shown to be pancreatic triglyceride lipaserelated protein 1 by sequence and enzymatic criteria, is longer than that of human pancreatic triglyceride lipase-related protein 1, 456 residues versus 451 (Giller et al. 1992, WickerPlanquart and Puigserver 1992) . The difference is explained by additional amino acids at the C-terminus of rat pancreatic triglyceride lipase-related protein 1. Human and rat pancreatic triglyceride lipase-related protein 2 may also differ, but in the length of the signal peptide not in the length of the mature protein (Giller et al. 1992 , Payne et al. 1994 . The reported human cDNA predicted a 17 amino acid signal peptide, whereas the rat cDNA had an open reading frame that predicted a 30 amino acid signal peptide; however, there was a second methionine, 16 amino acids from the N-terminus of the mature protein, that could function as the translation start site. Thus the rat protein may also have a short signal peptide. The predicted size of the mature protein was 452 amino acids for both species. In addition to the human and rat proteins, the sequences for porcine, rabbit, horse and guinea pig pancreatic triglyceride lipase, canine pancreatic triglyceride lipase-related protein 1 (originally reported as pancreatic triglyceride lipase), and mouse and coypu pancreatic triglyceride lipaserelated protein 2 have been reported (Aleman-Gomez et al. with oligonucleotide probes that were specific for each species. Adapted from Payne et al. 1994. and the pancreatic triglyceride lipase-related proteins reveal that the primary sequences are 63-68% identical and 77-81% homologous (Fig. 3) . ide lipase activity in the first year of life (Fredikzon and Olivecrona 1978) . The temporal expression pattern of pancreatic triglyceride lipase, pancreatic triglyceride lipase-related protein 1 and pancreatic triglyceride lipase-related protein 2 suggests that the pancreatic triglyceride lipase-related proteins may help to compensate for the low pancreatic triglyceride lipase activity in suckling animals to ensure efficient fat digestion in newborns who consume more fat per kilogram than at any other age.
PROTEIN STRUCTURE
Full understanding of the function of lipases in fat digestion requires detailed knowledge about the molecular details that determine the enzymatic mechanism of these lipases. An important adjunct to this goal is the availability of structural information about both the primary and tertiary structures of the proteins. Recent studies have characterized the cDNA sequences for pancreatic triglyceride lipase and the pancreatic The primary sequence data have been supplemented by gen bonded to Asp177 in a topology that mimics the catalytic triad of trypsin. the tertiary structure of human pancreatic triglyceride lipase determined by radiograph crystallography at 2.8 nm (Winkler Another observation about the crystal structure of pancreatic triglyceride lipase was the finding that the proposed cataet al. 1990 ). This analysis shows that pancreatic triglyceride lipase is divided into two domains, a globular N-terminal dolytic triad is covered by several surface loops. The position of these loops would sterically hinder access of substrate to the main formed by a central b-sheet core extending from amino acids 1-335 and a C-terminal domain consisting of a b-sheet catalytic site. A disulfide bridge between Cys238 and Cys262 defines the largest of these loops, termed the lid domain ( Fig.  sandwich structure (Fig. 4) . The domains are separated by a short, unstructured stretch of amino acids and the domains 4). Two shorter loops, formed by residues 76-80, the b-5 fold and by residues 213-217, also block the catalytic site. It is are stabilized by seven disulfide bonds. The observed folding pattern of pancreatic triglyceride lipase is conserved in a numclear that these loops would have to change conformation and open the active site to substrate before lipolysis could proceed. ber of hydrolases including several fungal lipases. This finding and the amino acid sequence homology of pancreatic triglycerAlthough there are no crystal structures of the pancreatic triglyceride lipase-related proteins, analysis of the primary ide lipase to hepatic and lipoprotein lipase support the concept of a lipase gene family that evolved from a common ancestral structures suggests that they should have conformations that are similar to pancreatic triglyceride lipase. Most of the difhydrolase.
Several other important observations came from the crystal fering amino acids are in unstructured surface loops, whereas the conserved amino acids are in regions that form the major structure of pancreatic triglyceride lipase. First, examination of the tertiary structure supported earlier suspicions that the determinants of secondary and tertiary structure. Notably, the disulfides and the regions of central b-sheets and b-sheet sandenzymatic mechanism of pancreatic triglyceride lipase resembles that of serine proteases and involves a serine-histidinewich structure are conserved as are the components of the active site, the b-5 fold, the nucleophile elbow (residues 175-aspartic acid catalytic triad. A serine residue at position 153 had been previously identified as the potential nucleophilic 183) and the catalytic triad. The lid domains are conserved in length and have nearly identical amino acid sequences. residue by chemical modification and inactivation of porcine pancreatic triglyceride lipase (Verger 1984) . In the crystal Given these similarities, it is highly probable that the tertiary structures of pancreatic triglyceride lipase-related protein 1 structure, Ser153 is located in the N-terminal domain with its side chain hydrogen bonded to His264, which in turn is hydroand pancreatic triglyceride lipase-related protein 2 resemble that of pancreatic triglyceride lipase.
LIPOLYSIS
The recent descriptions of the primary and tertiary structures of pancreatic triglyceride lipase along with the description of the pancreatic triglyceride lipase-related protein sequences have provided insight into the molecular details of pancreatic triglyceride lipase-catalyzed lipolysis. Pancreatic triglyceride lipase is a carboxyl esterase with a marked substrate preference for triglycerides over phospholipids (Verger 1984) . It shows very little activity against water-soluble substrates, greatly preferring water-insoluble substrates. When an oil-water interface is encountered, pancreatic triglyceride lipase activity increases markedly, a property termed interfacial activation (Sarda and Desnuelle 1958). Although pancreatic triglyceride lipase is secreted into the duodenum along with bile salts, the enzyme is inhibited by physiological concentrations of bile salts and is dependent on another pancreatic protein, colipase, for activity in the presence of bile salts. Each of these properties-substrate preference, interfacial activation, bile salt inhibition and colipase reactivation-must be determined by the structure of pancreatic triglyceride lipase.
The catalytic triad. Data from the crystal structure of human pancreatic triglyceride lipase and from chemical modification of porcine pancreatic triglyceride lipase strongly implicate a nucleophile-histidine-acidic amino acid triad (Ser153/ His264/Asp177) in the catalytic mechanism of pancreatic triglyceride lipase. Direct evidence for the function of these residues in catalysis was provided by site-specific mutagenesis of the cDNA encoding human pancreatic triglyceride lipase to produce recombinant proteins with mutations at each position and at Asp206, another candidate for the role of the acidic group (Lowe 1992 and . Replacing Ser153 with any of eight amino acids or changing His264 to a leucine completely inactivated pancreatic triglyceride lipase. Converting Asp177 Yang et al. 1990 ). In vitro studies suggested million years ago (Giller et al. 1992 , Sims et al. 1993 . The that polyunsaturated long-chain fatty acid esters were poorly conservation of functional residues and the apparent lack of hydrolyzed by pancreatic triglyceride lipase, but in vivo studies random divergence between pancreatic triglyceride lipase-reshowed that the long-chain polyunsaturated fatty acids of malated protein 1 and pancreatic triglyceride lipase argue strongly rine oils were effectively recovered in the fat tissue of pigs and for a biological role of pancreatic triglyceride lipase-related rats (Garton et al. 1952 , Storlein et al. 1987 . Recently, the protein 1. Additional substrates must be tested and other roles ability of pancreatic triglyceride lipase to hydrolyze a range of considered before a definitive statement about the physiologiacyl chains were re-examined with in vitro assays (Yang et al. cal function of pancreatic triglyceride lipase-related protein 1990). Acyl chains from C:14 to C:22 found in menhaden 1 can be made. oil triglycerides were all hydrolyzed by pancreatic triglyceride Pancreatic triglyceride lipase-related protein 2, on the lipase. There was only a sixfold difference between the best, other hand, has easily detectable activity against a variety of 18:1(n-9), and the worst 22:6(n-3), substrates. This difference substrates ( Table 1) . It has the highest specific activity against is unlikely to be significant in the duodenal lumen where there triglycerides and can hydrolyze short-, medium-and long-chain is a large excess of pancreatic triglyceride lipase present, which triglycerides (Andersson et al. 1996, Jennens and Lowe 1995b, should ensure that dietary polyunsaturated long-chain fatty Thirstrup et al. 1994 ). It has lower, but significant activity acids are efficiently digested.
against phospholipids and galactolipids. The activity against The substrate specificities of pancreatic triglyceride lipasephospholipids may be advantageous if pancreatic triglyceride related protein 1 and pancreatic triglyceride lipase-related lipase-related protein 2 is important in digesting phosphoprotein 2 have been less well characterized, but differences lipid-coated breast milk fat globules. An alternative reason for have been noted between these proteins and pancreatic triglycthe phospholipase activity is suggested by the observation that eride lipase. Pancreatic triglyceride lipase-related protein 1 pancreatic triglyceride lipase-related protein 2 is tightly assodid not hydrolyze triglycerides, phospholipids or galactolipids, ciated with the zymogen granule membrane (Wishart et al. and a substrate has not been identified for this pancreatic 1993). In this location, pancreatic triglyceride lipase-related triglyceride lipase homologue (Andersson et al. 1996, Giller protein 2 may participate in the release of the zymogen granule et al. 1992, Payne et al. 1994) . The reason for this lack of contents into the pancreatic ducts by altering membrane propactivity is not known and several potential explanations exist.
erties through hydrolysis of membrane phospholipids. Pancreatic triglyceride lipase-related protein 1 may require a
The amino acids that determine the differences in substrate different substrate, di-or monoglycerides, for example, or it specificity between pancreatic triglyceride lipase and pancremay require a cofactor other than colipase, or pancreatic triatic triglyceride lipase-related protein 2 have not been identiglyceride lipase-related protein 1 may be an inactive homofied. Simple comparison of the sequences corresponding to logue of pancreatic triglyceride lipase. This last explanation the catalytic site in the pancreatic triglyceride lipase crystal seems unlikely given the mutational rate of pancreatic triglycstructure reveals remarkable conservation between pancreatic eride lipase-related protein 1 and the location of the mutatriglyceride lipase and pancreatic triglyceride lipase-related tions. Nonfunctional genes mutate at higher rates than their protein 2 with no obvious changes that should greatly affect functional counterparts, and this has not occurred with pancrethe properties of the catalytic site. The most striking differatic triglyceride lipase-related protein 1. Pancreatic triglycerences are in the lid domain, but these residues would be exide lipase-related protein 1 is as conserved among various pected to move away from the catalytic site by analogy to species as are pancreatic triglyceride lipase and pancreatic tripancreatic triglyceride lipase and should not affect substrate glyceride lipase-related protein 2. Furthermore, the functional specificity. It is possible that the conformation of the catalytic residues of pancreatic lipase-related protein 1, such as the site is affected by other regions of the protein and differs sigcatalytic triad, and the major determinants of structure have nificantly from that of pancreatic triglyceride lipase, but such been preserved, leaving the majority of divergent residues conchanges cannot be predicted by simple inspection of the pricentrated in other regions of the protein. This nonrandom mary sequences. The crystal structure of pancreatic triglyceride pattern of divergent residues is in distinct contrast to the exlipase-related protein 2 is necessary to aid in resolving the pected results of random mutations, which would distribute mutations throughout the protein. Certainly, mutations in bioissue of substrate specificity.
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BILE SALTS AND COLIPASE
Despite its high activity against triglycerides, pancreatic triglyceride lipase is inhibited by physiological concentrations of bile salts, an undesirable property for a lipase acting on dietary fats in the duodenum where bile salts are present (Verger 1984) . Pancreatic triglyceride lipase activity is restored by another pancreatic protein, colipase. Colipase is a small molecular weight, 11 kD, protein that has been described in multiple species from dogfish to humans (Lowe et al. 1990) . It is secreted from pancreatic acinar cells as a proform, procolipase and is converted to mature colipase by cleavage of an amino-terminal pentapeptide in the duodenum. The physiological importance of this cleavage is controversial. There is in vitro evidence that procolipase is less active than colipase at alkaline pH, but this concept was recently challenged when it was shown that procolipase is as effective as colipase at neutral pH (Larsson and Erlanson-Albertsson 1991) . Addi- ostatin, that regulates satiety and fat intake (Erlanson-Albertsson 1992) .
Even though the function of converting procolipase to coliported for the crystal structure of pancreatic triglyceride lipase pase is unsettled, the function of colipase in restoring activity alone. to bile salt-inhibited pancreatic triglyceride lipase is well es-
The importance of the interaction with the C-terminal tablished. What is less clear are the molecular details of the domain was brought into question by a report of two pancreatic mechanism involved in the interaction between pancreatic triglyceride lipase mutants lacking the C-terminal domain triglyceride lipase and colipase. There are kinetic and physical (Jennens and Lowe 1995a) . The mutants, truncated after data that colipase and pancreatic triglyceride lipase form a Phe336 or Tyr341, had a specific activity that was only 20% complex at the substrate interface. The most dramatic eviof that of wild-type pancreatic triglyceride lipase, but the activdence for this structure was provided by X-ray crystallography ity was dependent on colipase. In this same study, pancreatic of a complex between porcine procolipase and human pancretriglyceride lipase mutants with alterations in Lys400 and atic triglyceride lipase (van Tilbeurgh et al. 1992) . In this Asp390 were reported to be fully active, indicating that the salt structure, procolipase was bound to the pancreatic triglyceride bridges formed with colipase are not required for the efficient lipase C-terminal domain through two salt bridges involving reactivation of pancreatic triglyceride lipase by colipase. These Lys400 and Asp390 of pancreatic triglyceride lipase (Fig. 5) .
results demonstrated that the C-terminal domain is not essenProcolipase formed three major loops stabilized by disulfide tial for the interaction between colipase and pancreatic triglycbridges. The tips of the loops contained primarily hydrophobic eride lipase to occur, although the decreased activity of the groups and extended away from pancreatic triglyceride lipase, deletion mutants could be attributed entirely or in part to the suggesting that these loops may mediate interactions with the lack of that interaction. Importantly, these findings indicated substrate interface (Fig. 6) . Procolipase did not form any interthat colipase could interact with the N-terminal domain of actions with the N-terminal domain and did not alter the pancreatic triglyceride lipase. conformation of pancreatic triglyceride lipase from that reAn interaction of colipase with the N-terminal domain of pancreatic triglyceride lipase was also demonstrated by a second crystal structure of procolipase complexed with pancreatic triglyceride lipase (van Tilbeurgh et al. 1993) . In this study, the crystallization media contained mixed micelles of phospholipid and detergent, which formed an interface. Colipase was associated with the C-terminal domain of pancreatic triglyceride lipase, but it also formed an interaction with the N-terminal domain of pancreatic triglyceride lipase (Fig. 7) . Several conformational changes in pancreatic triglyceride lipase allowed these interactions to form. The most dramatic was the rearrangement of the lid domain, resulting in movement of these residues toward colipase and in the uncovering of the catalytic site. A hinge movement of the C-terminal domain facilitated the formation of interactions between Glu15 of colipase and Asn241 in the lid and between Arg38 of colipase and Ser243 and Val246 of the lid. The importance of these interactions in the mechanism of lipolysis has not been ascertained, but it is reasonable to speculate that the bonds between colipase and the lid domain stabilize the lid in the open conformation and The dashes indicate that a space was placed to optimize the alignment. The residues that interact with the protein core in the crystal structure of pancreatic triglyceride lipase are in bold. The references for each structure are given in the text.
The crystal structure of the colipase-pancreatic triglyceride clearly showed a conformational change in pancreatic triglyc-
The a-carbon backbone is given. Colipase, the lid domain and b-5 loop eride lipase (Fig. 7) . Not only did the lid domain move, but lytic site, the b-5 loop. Together these movements configured the catalytic site to accept substrate. Concurrent studies on vided by comparisons with pancreatic triglyceride lipase-refungal lipases have also shown similar conformational changes lated protein 2 (Jennens and Lowe 1995b This hypothesis is supported by two additional studies. First, protein 2, which was completely inhibited by bile salts a pancreatic lipase that is quite homologous to the pancreatic (Thirstrup et al. 1994) . Colipase increased the activity of rat triglyceride lipase-related protein 2 family with one exception pancreatic triglyceride lipase-related protein 2, but the inwas isolated from guinea pig (Hjorth et al. 1993) . It is missing crease was only 1.5-to 4-fold, much less than colipase increases sequence corresponding to the lid domain and was predicted pancreatic triglyceride lipase activity. Coypu pancreatic tri-
to have an open catalytic site (Fig. 8) . This hypothesis was glyceride lipase-related protein 2 did not show any response confirmed experimentally by demonstrating that the lipase to the addition of colipase. These observations demonstrated possesses high activity against monomeric substrates and is not that pancreatic triglyceride lipase-related protein 2 can overactivated by interfaces. Apparently, the guinea pig lipase is a come the presence of bile salts without colipase and that it naturally occurring mutant with a deletion of the lid domain. contains residues that function like colipase and permit activThe properties of this lipase support the enzyme model of ity in the presence of bile salts. These functional differences interfacial activation. between pancreatic triglyceride lipase-related protein 2 and
In the second study, deletion mutants of pancreatic triglycpancreatic triglyceride lipase provide a unique opportunity to eride lipase were created, expressed and characterized (Jennens identify the residues responsible for important interactions . One mutation removed all of the lid domain with colipase and with mixed micelles of bile salts and triglycand the second mutation removed a portion of the lid domain, erides.
the a-helix covering the catalytic site (Fig. 9) . Both mutants had decreased, but easily detectable activity against emulsions INTERFACIAL ACTIVATION of triglycerides and taurodeoxycholate compared with the wild-type lipase. Like the guinea pig lipase, the mutants were The ability to hydrolyze water-insoluble substrates and the not activated by interfaces and could hydrolyze water-soluble dependence on colipase distinguish pancreatic triglyceride lisubstrates at a high rate (Fig. 10) . This finding demonstrated pase from other enzymes that act on water-soluble substrates, that the lid domain is required for interfacial activation. A but interfacial activation is the property that most clearly distinguishes pancreatic triglyceride lipase. Pancreatic triglyceride lipase has activity against monomeric, water-soluble substrates, but its specific activity increases greatly when the substrate forms water-insoluble particles such as micelles or emulsions. Speculation about the mechanism underlying the increased activity of pancreatic triglyceride lipase at an oil-water interface focuses on two models, an enzyme model and a substrate model. The enzyme model purports that a change in the conformation of pancreatic triglyceride lipase leads to interfacial activation. The substrate model suggests that the formation of substrate particles either increases the local concentration of 
CONCLUSION
Although the importance of pancreatic lipase in fat digestion was recognized more than a century ago, human pancreatic triglyceride lipase was first isolated about 20 years ago. Many of the studies on pancreatic triglyceride lipase since that time described the kinetic properties of pancreatic triglyceride lipase. It is only in this decade that the molecular mechanism of lipolysis has been dissected and the detailed molecular interactions underlying lipolysis have begun to be understood. There is still much to be described and many unanswered questions, but one can foresee the time when this information will lead to rational nutrition therapies for patients with pan- role for the lid domain in interfacial binding was also demon-
